Mammogen: Funding, Investors & Team (Oct 2026)
Mammogen is a female-led precision health company that is committed to dramatically improving the detection, diagnosis, and treatment of diseases that affect women's health. It also works to build a vibrant global community that supports, empowers, and uplifts women through their entire survivor journey, from beginning to end. With the help of a clinical-stage, patent-pending technology called our flagship genTRU diagnostic programme, we can reliably diagnose breast cancer at all stages of the disease by detecting changes in RNA expression patterns seen in both blood and saliva.
Mammogen has raised $30.0M across 2 funding rounds on record, the most recent a Series A of $30.0M announced in Jun 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Mammogen Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Mammogen Funding Rounds
Mammogen raised $30k in an undisclosed round announced in Feb 2023.
3.3 years later, a Series A of $30.0M was announced in Jun 2026.
Mammogen Founders and Leadership Team
Contact details for the Mammogen team: 1 of 2 have an email address on file.
Start 14-day free trial →Mammogen Funding Compared to Other Biotechnology Startups
Mammogen's latest round of $30.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mammogen in Biotechnology and Aliso Viejo
Companies Similar to Mammogen
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Mammogen Funding FAQs
What does Mammogen do?
Mammogen is a female-led precision health company that is committed to dramatically improving the detection, diagnosis, and treatment of diseases that affect women's health. It also works to build a vibrant global community that supports, empowers, and uplifts women through their entire survivor journey, from beginning to end. With the help of a clinical-stage, patent-pending technology called our flagship genTRU diagnostic programme, we can reliably diagnose breast cancer at all stages of the disease by detecting changes in RNA expression patterns seen in both blood and saliva.
How much funding has Mammogen raised?
Mammogen has raised $30.0M across 2 rounds on record. The most recent is a Series A of $30.0M announced in Jun 2026.
When did Mammogen last raise funding?
Mammogen's most recent funding round on record is a Series A of $30.0M, announced in Jun 2026.
Who founded Mammogen?
FundedIQ lists Elizabeth Cormier (Founder), Marty Keiser (Founder) at Mammogen.
Where is Mammogen headquartered?
Mammogen is based in Aliso Viejo, California, United States.
How many employees does Mammogen have?
Mammogen is in the 1-10 employee band.
How does Mammogen's funding compare to other Biotechnology startups?
Mammogen's latest round of $30.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Mammogen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mammogen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.